Mulder JW - Search Results

1

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Beijnen JH. de Maat MM, et al. Among authors: mulder jw. Br J Clin Pharmacol. 2002 Oct;54(4):378-85. doi: 10.1046/j.1365-2125.2002.01657.x. Br J Clin Pharmacol. 2002. PMID: 12392585 Free PMC article. Clinical Trial.

2

Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients.

Ter Heine R, Mulder JW, van Gorp EC, Wagenaar JF, Beijnen JH, Huitema AD. Ter Heine R, et al. Among authors: mulder jw. Br J Clin Pharmacol. 2010 May;69(5):475-83. doi: 10.1111/j.1365-2125.2010.03634.x. Br J Clin Pharmacol. 2010. PMID: 20573083 Free PMC article.

3

Discrepancies between medical and pharmacy records for patients on anti-HIV drugs.

de Maat MM, Frankfort SV, Mathôt RA, Mulder JW, Meenhorst PL, van Gorp EC, Koks CH, Hoetelmans RM, de Boer A, Beijnen JH. de Maat MM, et al. Among authors: mulder jw. Ann Pharmacother. 2002 Mar;36(3):410-5. doi: 10.1345/aph.1A167. Ann Pharmacother. 2002. PMID: 11898804

4

Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals.

De Maat MM, Mathôt RA, Veldkamp AI, Huitma AD, Mulder JW, Meenhorst PL, Van Gorp EC, Carlier H, Beijnen JH. De Maat MM, et al. Among authors: mulder jw. Pharmacol Res. 2002 Sep;46(3):295-300. doi: 10.1016/s1043-6618(02)00146-9. Pharmacol Res. 2002. PMID: 12220974

5

Drug interactions between antiretroviral drugs and comedicated agents.

de Maat MM, Ekhart GC, Huitema AD, Koks CH, Mulder JW, Beijnen JH. de Maat MM, et al. Among authors: mulder jw. Clin Pharmacokinet. 2003;42(3):223-82. doi: 10.2165/00003088-200342030-00002. Clin Pharmacokinet. 2003. PMID: 12603174 Review.

6

Subtherapeutic antiretroviral plasma concentrations in routine clinical outpatient HIV care.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Mairuhu AT, Beijnen JH. de Maat MM, et al. Among authors: mulder jw. Ther Drug Monit. 2003 Jun;25(3):367-73. doi: 10.1097/00007691-200306000-00018. Ther Drug Monit. 2003. PMID: 12766566

7

Incidence and risk factors for nevirapine-associated rash.

de Maat MM, ter Heine R, Mulder JW, Meenhorst PL, Mairuhu AT, van Gorp EC, Huitema AD, Beijnen JH. de Maat MM, et al. Among authors: mulder jw. Eur J Clin Pharmacol. 2003 Sep;59(5-6):457-62. doi: 10.1007/s00228-003-0613-3. Epub 2003 Aug 12. Eur J Clin Pharmacol. 2003. PMID: 12920493

8

Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment.

de Maat MM, ter Heine R, van Gorp EC, Mulder JW, Mairuhu AT, Beijnen JH. de Maat MM, et al. Among authors: mulder jw. AIDS. 2003 Oct 17;17(15):2209-14. doi: 10.1097/00002030-200310170-00009. AIDS. 2003. PMID: 14523278

9

Race is not associated with nevirapine pharmacokinetics.

de Maat MM, Nellen JF, Huitema AD, Wit FW, Mulder JW, Prins JM, Beijnen JH. de Maat MM, et al. Among authors: mulder jw. Ther Drug Monit. 2004 Aug;26(4):456-8. doi: 10.1097/00007691-200408000-00018. Ther Drug Monit. 2004. PMID: 15257078

10

Practical guidelines to interpret plasma concentrations of antiretroviral drugs.

Kappelhoff BS, Crommentuyn KM, de Maat MM, Mulder JW, Huitema AD, Beijnen JH. Kappelhoff BS, et al. Among authors: mulder jw. Clin Pharmacokinet. 2004;43(13):845-53. doi: 10.2165/00003088-200443130-00002. Clin Pharmacokinet. 2004. PMID: 15509183 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters